Qun Zhao

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

Ping’an Ding, Honghai Guo, Chenyu Sun et al. · BMC Gastroenterology · 2022 · 152 citations · Full text

Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1

Yan Liang, Qun Zhao, Liqiao Fan et al. · Biomedicine & Pharmacotherapy · 2015 · 48 citations

Cancer Research, Medicine, Pathology +11

Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial

Honghai Guo, Ping’an Ding, Chenyu Sun et al. · Frontiers in Oncology · 2022 · 45 citations · Full text

microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo

Zhuoqi Zhang, Yong Li, Liqiao Fan et al. · Experimental and Therapeutic Medicine · 2015 · 42 citations · Full text